Back to ACAD
Palo Alto Investors LP ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$50.1M
Q3 2026
Peak value
$72.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $66.3M |
| Q1 2026 | $63.9M |
| Q2 2026 | $72.5M |
| Q2 2026 | $72.5M |
| Q3 2026 | $50.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $50.1M | 2.49M | — | — |
| Q2 2026 | $72.5M | 2.86M | — | — |
| Q2 2026 | $72.5M | 2.86M | — | — |
| Q1 2026 | $63.9M | 2.87M | — | — |
| Q4 2025 | $66.3M | 2.48M | — | — |
Other funds holding ACAD
$954.9M
$864.7M
$386.3M
$383.2M
$377M
$323.1M